Thus, the activation of the ZEB2/pCRAF/pASK1 axis induced the increase prevalence of quiescent cancer stem cells (QCSCs), with a stemness/EMT phenotype followed by the chemotherapy treatment of tumour xenografts, especially in a chemotherapy-quiescent state. This evidence concerns the gene ZEB2 and neoplasm.